Allergen Diagnostics Growth InBio specializes in allergens, diagnostic systems, and testing for environmental and food allergies, with a broad product catalog and ongoing R&D. This creates opportunities to upsell contract research and custom testing for labs, manufacturers, and academic partners, leveraging direct access to the scientific team to tailor solutions.

Strategic Partnerships The company has active partnerships across development and distribution channels, including collaboration with GX Group, LGC Standards, and Polycarbin for circular solutions. These networks offer pathways to expand reach, co-develop products, and place InBio’s testing offerings through distributors and sustainable initiatives in new regions.

Innovation Pipeline InBio has advanced technologies such as ELISA 2.0, MARIA for Foods, human IgE monoclonal antibodies, and integrated mass spectrometry services. This positions them to cross-sell comprehensive allergen analysis packages to research labs, clinical diagnostics groups, and pharma/biotech developers, as well as to secure contract research work.

Market Growth Potential With NIH funding support and a healthy revenue base, InBio appears poised for expanded client acquisition and multi-year service agreements. The small-to-mid-size team suggests high responsiveness and potential to scale through partnerships, distributors, and targeted government and industry programs.

Sustainability Advantage The circular lab plastics initiative demonstrates a commitment to sustainability, appealing to labs and manufacturers seeking green operations. This can be monetized through eco-friendly testing workflows, recycling services, and sustainability-focused partnerships as part of a broader value proposition.